Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AETHLON MEDICAL INCAEMD · Entity 8580 | Director | June 30, 2026 | July 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AETHLON MEDICAL INC
Report date June 30, 2026 · Filed July 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,663 |
Reported balance
After 2026-06-30 transaction · row 1
1 source rowRow 1 · 2026-06-30 · Tax withholding · Disposed 2,182 · Balance 20,663 F1: The Reporting Person forfeited 2,182 shares of common stock upon conversion of an aggregate 5,454 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 17, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person forfeited 2,182 shares of common stock upon conversion of an aggregate 5,454 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 17, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2026 Filed Jul 1, 2026 21:15 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 2,182 | $0.82 | $1,789.24 |
DisclosureSEC source: 0001683168-26-005225 · ownership.xml · nonDerivative · entry 1 Gikakis Nicolas · CIK 0001982603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,663 F1 · shares: The Reporting Person forfeited 2,182 shares of common stock upon conversion of an aggregate 5,454 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 17, 2026. Read SEC document |
| April 17, 2026 Filed Apr 21, 2026 21:00 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantCommon Stock | 21,815 | $2.29 | $49,956.35 |
DisclosureSEC source: 0001683168-26-003112 · ownership.xml · nonDerivative · entry 1 Gikakis Nicolas · CIK 0001982603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,844 F1 · shares: The Reporting Person was granted RSUs that vest in four equal quarterly installments on each of June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027, subject to the Reporting Person's continued service with the Company on each such vesting date. Read SEC document |
| March 31, 2026 Filed Apr 1, 2026 23:27 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 178 | $2.19 | $389.82 |
DisclosureSEC source: 0001683168-26-002588 · ownership.xml · nonDerivative · entry 1 Gikakis Nicolas · CIK 0001982603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,464 F1 · shares: The Reporting Person forfeited 178 shares of common stock upon conversion of an aggregate 268 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 25, 2025. Read SEC document |
| December 31, 2025 Filed Jan 2, 2026 23:42 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 179 | $2.77 | $495.83 |
DisclosureSEC source: 0001683168-26-000051 · ownership.xml · nonDerivative · entry 1 Gikakis Nicolas · CIK 0001982603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,357 F1 · shares: The Reporting Person forfeited 179 shares of common stock upon conversion of an aggregate 268 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 25, 2025. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:15 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 1,786 | $0.75 | $1,337.71 |
DisclosureSEC source: 0001683168-25-007375 · ownership.xml · nonDerivative · entry 1 Gikakis Nicolas · CIK 0001982603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,683 F1 · shares: The Reporting Person forfeited 1,786 shares of common stock upon conversion of an aggregate 4,465 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 25, 2025. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 20:03 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 1,786 | $1.20 | $2,143.20 |
DisclosureSEC source: 0001683168-25-004858 · ownership.xml · nonDerivative · entry 1 Gikakis Nicolas · CIK 0001982603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,004 F1 · shares: The Reporting Person forfeited 1,786 shares of common stock upon conversion of an aggregate 4,465 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 25, 2025. Read SEC document |
| April 23, 2025 Filed Apr 25, 2025 20:10 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantCommon Stock | 142,857 | $0.35 | $49,999.95 |
DisclosureSEC source: 0001683168-25-002838 · ownership.xml · nonDerivative · entry 1 Gikakis Nicolas · CIK 0001982603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,320 F1 · shares: The Reporting Person was granted RSUs that vest in four equal quarterly installments on each of June 30, 2025, September 30, 2025, December 31, 2025 and March 31, 2026, subject to the Reporting Person's continued service with the Company on each such vesting date. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 22:03 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 3,289 | $0.36 | $1,177.46 |
DisclosureSEC source: 0001683168-25-002185 · ownership.xml · nonDerivative · entry 1 Gikakis Nicolas · CIK 0001982603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,463 F1 · kind: The Reporting Person forfeited 3,289 shares of common stock upon conversion of an aggregate 8,224 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 17, 2023. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 22:15 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 3,289 | $0.86 | $2,828.54 |
DisclosureSEC source: 0001683168-25-000091 · ownership.xml · nonDerivative · entry 1 Gikakis Nicolas · CIK 0001982603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,752 F1 · kind: The Reporting Person forfeited 3,289 shares of common stock upon conversion of an aggregate 8,224 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 17, 2024. Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 21:30 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 3,289 | $0.47 | $1,532.67 |
DisclosureSEC source: 0001683168-24-006799 · ownership.xml · nonDerivative · entry 1 Gikakis Nicolas · CIK 0001982603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,041 F1 · kind: The Reporting Person forfeited 3,289 shares of common stock upon conversion of 8,223 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 17, 2024. Read SEC document |
| June 28, 2024 Filed Jul 1, 2024 20:15 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 5,244 | $0.50 | $2,616.76 |
DisclosureSEC source: 0001415889-24-018577 · form4-07012024_040704.xml · nonDerivative · entry 1 Gikakis Nicolas · CIK 0001982603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,330 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/16/24 Read SEC document |
| April 16, 2024 Filed Apr 17, 2024 20:56 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantCommon Stock | 32,894 | $1.52 | $49,998.88 |
DisclosureSEC source: 0001415889-24-011025 · form4-04172024_080402.xml · nonDerivative · entry 1 Gikakis Nicolas · CIK 0001982603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,574 F1 · shares: The RSU's vests in four equal quarterly installments on 6/30/24, 9/30/24, 12/31/24 and 3/31/25. Read SEC document |
| March 29, 2024 Filed Apr 1, 2024 21:07 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 1,954 | $1.68 | $3,282.72 |
DisclosureSEC source: 0001415889-24-009568 · form4-04012024_090445.xml · nonDerivative · entry 1 Gikakis Nicolas · CIK 0001982603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,680 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/28/23 Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 23:06 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 1,954 | $2.19 | $4,279.26 |
DisclosureSEC source: 0001209191-24-000226 · doc4.xml · nonDerivative · entry 1 Gikakis Nicolas · CIK 0001982603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,634 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/28/23 F2 · balance_after: The end of period holdings reflect a 1-10 reverse stock split effected by the Issuer on October 4, 2023. Read SEC document |
| September 29, 2023 Filed Sep 29, 2023 21:54 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 19,541 | $0.23 | $4,494.43 |
DisclosureSEC source: 0001209191-23-050878 · doc4.xml · nonDerivative · entry 1 Gikakis Nicolas · CIK 0001982603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,873 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 7/3/23 Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 21:04 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantCommon Stock | 195,414 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041591 · doc4.xml · nonDerivative · entry 1 Gikakis Nicolas · CIK 0001982603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,414 F1 · shares: The RSU vests in four equal quarterly installments over one year from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.